Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
Abstract The aim of this article is to demonstrate extreme interindividual variability of piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients and to emphasize the need for the practice of routine PIP/TAZO plasma concentrations measurement in order to ensure o...
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Wiley
2023-03-01
|
| Schriftenreihe: | Clinical Case Reports |
| Schlagworte: | |
| Online Zugang: | https://doi.org/10.1002/ccr3.7032 |